Zhuoran Qi

机构：Fudan University, Zhongshan Hospital

发表论文 22 篇 · 总被引 297 次 · h-index 9

代表论文

• Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma (2022 · Molecular Oncology · 被引 66)
• Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma (2023 · Research · 被引 53)
• Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization (2021 · Frontiers in Immunology · 被引 37)
• Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma (2025 · Acta Pharmaceutica Sinica B · 被引 16)
• Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway (2023 · Hepatology International · 被引 15)
• Lobe-Specific Node Dissection Can Be a Suitable Alternative to Systematic Lymph Node Dissection in Highly Selective Early-Stage Non-Small-Cell Lung Cancer Patients: A Meta-Analysis (2020 · Annals of Thoracic and Cardiovascular Surgery · 被引 15)